Anxiolytic therapy and Ear infection staphylococcal
Ear infection staphylococcal is reported only by a few people with Anxiolytic therapy.
The study analyzes which people have Ear infection staphylococcal with Anxiolytic therapy. It is created by eHealthMe based on 1 person who has Ear infection staphylococcal and Anxiolytic therapy from the Food and Drug Administration (FDA), and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1 person who has Anxiolytic Therapy and Ear Infection Staphylococcal is studied.
What is Anxiolytic therapy?
Anxiolytic therapy is found to be associated with 4,858 drugs and 5,242 conditions by eHealthMe.
What is Ear infection staphylococcal?
Ear infection staphylococcal (ear infection by staphylococcal bacteria) is found to be associated with 197 drugs and 121 conditions by eHealthMe.
Number of Ear infection staphylococcal in Anxiolytic therapy reports submitted per year:
Gender of people who have Anxiolytic Therapy and experienced Ear Infection Staphylococcal *:
- female: 0.0 %
- male: 100 %
Common co-existing conditions for these people *:
- High Blood Pressure: 1 person, 100.00%
- High Blood Cholesterol: 1 person, 100.00%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 100.00%
- Diabetes: 1 person, 100.00%
- Depression: 1 person, 100.00%
- Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 100.00%
- Asthma: 1 person, 100.00%
Common drugs taken by these people *:
- Singulair: 1 person, 100.00%
- Proair Hfa: 1 person, 100.00%
- Novolog: 1 person, 100.00%
- Nexium: 1 person, 100.00%
- Lipitor: 1 person, 100.00%
- Humira: 1 person, 100.00%
- Exforge: 1 person, 100.00%
- Dulera: 1 person, 100.00%
- Cymbalta: 1 person, 100.00%
Common symptoms for these people *:
- Wound Infection: 1 person, 100.00%
- Wound Complication: 1 person, 100.00%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 100.00%
- Cuts And Puncture Wounds: 1 person, 100.00%
- Drug Level Decreased: 1 person, 100.00%
- External Ear Inflammation: 1 person, 100.00%
- Facial Pain: 1 person, 100.00%
- Hypoacusis (loss of hearing): 1 person, 100.00%
- Localised Infection (infection at the single location): 1 person, 100.00%
- Middle Ear Effusion (fluid in middle ear): 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Ear infection staphylococcal?Check whether Ear infection staphylococcal is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Treatments, associated drugs and conditions:
COVID vaccines that are related to Ear infection staphylococcal:
- Ear infection staphylococcal in Moderna COVID Vaccine
- Ear infection staphylococcal in Pfizer BioNTech Covid Vaccine
- Ear infection staphylococcal in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Ear infection staphylococcal:
- Ear infection staphylococcal (197 drugs)
All the conditions that are associated with Ear infection staphylococcal:
- Ear infection staphylococcal (121 conditions)
How the study uses the data?
The study is based on Ear infection staphylococcal and Anxiolytic therapy, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Oramorph Sr vs. Cannabis - 2 seconds ago
- Butabarbital vs. Profen - 14 seconds ago
- Celexa and Sleep Disorder - 15 seconds ago
- Clorazepate Dipotassium vs. Metoprolol Tartrate - 17 seconds ago
- Zafirlukast vs. Benadryl - 21 seconds ago
- Tiamate vs. Zaroxolyn - 22 seconds ago
- Catapres-Tts-1 vs. Clonazepam - 22 seconds ago
- Syndopa Cr vs. Namenda - 31 seconds ago
- Aldactazide vs. Benicar - 35 seconds ago
- Doxy-Sleep-Aid vs. Clonazepam - 35 seconds ago